Serum response factor is modulated by the SUMO-1 conjugation system

Biochemical and Biophysical Research Communications

Volumn 306, Issue 1, 2003, Pages 32-38

  Matsuzaki, Kazuhito ^a,b,c   Minami, Takeshi ^a   Tojo, Masahide ^a   Honda, Yoshiomi ^b   Uchimura, Yasuhiro ^a   Saitoh, Hisato ^a   Yasuda, Hideyo ^d   Nagahiro, Shinji ^c   Saya, Hideyuki ^b   Nakao, Mitsuyoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

PML; Serum response; SRF; SUMO 1; Transcription

Indexed keywords

ALANINE; LYSINE; SERUM RESPONSE FACTOR; SUMO 1 PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CHEMICAL MODIFICATION; CONFOCAL LASER MICROSCOPY; CONJUGATION; CONTROLLED STUDY; DNA BINDING MOTIF; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEIN TRANSPORT; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

EID: 0037716544     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00910-0     Document Type: Article

References (37)

1. Norman C., Runswick M., Pollock R., Treisman R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell. 55:1988;989-1003.
2. Arias J., Albert A.S., Brindle P., Claret F.X., Smeal T., Karin M., Feramisco J., Montminy M. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature. 370:1994;226-229.
3. Treisman R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:1996;205-215.
4. Hill C.S., Wynne J., Treisman R. The Rho family GTPases RhoA, Rac1 and CDC42Hs regulate transcriptional activity by SRF. Cell. 81:1995;1159-1170.
5. Wang Y., Falasca M., Schlessinger J., Malstorm S., Tsichlis P., Settleman J., Hu W., Lin B., Prywes R. Activation of the c-fos serum response element by phosphatidylinositol 3-kinase and rho pathways in HeLa cells. Cell Growth Differ. 9:1998;513-522.
6. Desterro J.M., Rodriguez M.S., Kemp G.D., Hay R.T. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274:1999;10618-10624.
7. Okuma T., Honda R., Ichikawa G., Tsumagari N., Yasuda H. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Commun. 254:1999;693-698.
8. Schmidt D., Müller S. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. USA. 99:2002;2872-2877.
9. Sachdev S., Bruhn L., Sieber H., Pichler A., Melchior F., Grosschedl R. PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. Genes Dev. 15:2001;3088-3103.
10. Kahyo T., Nishida T., Yasuda H. Involvement of PIAS1 in the Sumoylation of tumor suppressor p53. Mol. Cell. 8:2001;713-718.
11. Pichler A., Gast A., Seeler J.S., Dejean A., Melchior F. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell. 108:2002;109-120.
12. Rodriguez M.S., Dargemont C., Hay R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276:2001;12654-12659.
13. Sampson D.A., Wang M., Matunis M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 276:2001;21664-21669.
14. Sternsdorf T., Jensen K., Reich B., Will H. The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellular localization, and modification by small Ubiquitin-like modifiers. J. Biol. Chem. 274:1999;12555-12566.
15. Müller S., Matunis M.J., Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17:1998;61-70.
16. Matunis M.J., Coutavas E., Blobel G. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135:1996;1457-1470.
17. Desterro J.M., Rodriguez M.S., Hay R.T. SUMO-1 modification of IkB alpha inhibits NF-κB activation. Mol. Cell. 2:1998;233-239.
18. Ishov A.M., Sotnikov A.G., Negorev D., Vladimirova O.V., Neff N., Kamitani T., Yeh E.T.H., Strauss J.F., Maul G.G. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147:1999;221-234.
19. Zhong S., Salomoni P., Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2:2000;E85-E90.
20. Hatta M., Fukamizu A. PODs in the nuclear spot: enigmas in the magician's pot. Science's STKE. 96:2001;PE1.
21. Fogal V., Gostissa M., Sandy P., Zacchi P., Sternsdorf T., Jensen K., Pandolfi P.P., Will H., Schneider C., Del Sal G. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19:2000;6185-6195.
22. Jang M.S., Ryu S.W., Kim E. Modification of Daxx by small ubiquitin-related modifier-1. Biochem. Biophys. Res. Commun. 295:2002;495-500.
23. Tojo M., Matsuzaki K., Minami T., Honda Y., Yasuda H., Chiba T., Saya H., Fujii-Kuriyama Y., Nakao M. The aryl hydrocarbon receptor nuclear transporter is mudulated by the SUMO-1 conjugating system. J. Biol. Chem. 277:2002;46576-46585.
24. Goodson M.L., Hong Y., Rogers R., Matunis M.J., Park-Sarge O.K., Sarge K.D. SUMO-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor. J. Biol. Chem. 276:2001;18513-18518.
25. Gostissa M., Hengstermann A., Fogal V., Sandy P., Schwarz S.E., Scheffner M., Del Sal G. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18:1999;6462-6471.
26. Rodriguez M.S., Desterro J.M.P., Lain S., Midgley C.A., Lane D.P., Hay R.T. SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18:1999;6455-6461.
27. Müller S., Berger M., Lehembre F., Seeler J.S., Haupt Y., Dejean A. c-Jun and p53 activity is modulated by SUMO-1 modification. J. Biol. Chem. 275:2000;13321-13329.
28. Ross S., Best J.L., Zon L.I., Gill G. SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization. Mol. Cell. 10:2002;831-842.
29. Sapetschnig A., Rischitor G., Braun H., Doll A., Schergaut M., Melchior F., Suske G. Transcription factor Sp3 is silenced through SUMO modification by PIAS1. EMBO J. 21:2002;5206-5215.
30. David G., Neptune M.A., DePinho R.A. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J. Biol. Chem. 277:2002;23658-23663.
31. Matsuzaki K., Minami T., Tojo M., Honda Y., Saitoh N., Nagahiro S., Saya H., Nakao M. PML-nuclear bodies are involved in cellular serum response. Genes Cells. 8:2003;275-286.
32. Fujita N., Shimotake N., Ohki I., Chiba T., Saya H., Shirakawa M., Nakao M. Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1. Mol. Cell. Biol. 20:2000;5107-5118.
33. Treisman R. Ternary complex factors: growth factor regulated transcriptional activators. Curr. Opin. Genet. Dev. 4:1994;96-101.
34. Sotiropoulos A., Gineitis D., Copeland J., Treisman R. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell. 98:1999;159-169.
35. Khan M.M., Nomura T., Kim H., Kaul S.C., Wadhwa R., Shinagawa T., Ichikawa-Iwata E., Zhong S., Pandolfi P.P., Ishii S. Role of PML and PML-RARα in Mad-mediated transcriptional repression. Mol. Cell. 7:2001;1233-1243.
36. Lee S.K., Kim J.H., Lee Y.C., Cheong J.H., Lee J.W. Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-κB, and serum response factor. J. Biol. Chem. 275:2000;12470-12474.
37. Villian S., Gaken J.A., Gingold E.B., Kouzarides T., Chang K.S., Farzaneh F. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein. Oncogene. 16:1998;2843-2853.